NKTR

Nektar Therapeutics News Headlines

$13.7
*  
0.33
2.35%
Get NKTR Alerts
*Delayed - data as of Oct. 31, 2014 12:19 ET  -  Find a broker to begin trading NKTR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    NKTR Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Update: AstraZeneca Moves Closer To EU Approval For Moventig
9/30/2014 3:41:00 AM - Seeking Alpha


Nektar/AstraZeneca's Moventig a Step Closer to EU Approval - Analyst Blog
9/29/2014 5:10:00 PM - Zacks.com


AMBI Snapped Up, ALIM''s Iluvien Gets FDA Nod, GLYC Faces Glitch In Study
9/29/2014 2:04:00 AM - RTT News


Interesting NKTR Put And Call Options For May 2015
9/26/2014 10:55:09 AM - BNK Invest


Sector Update: Health-Care Stocks Mixed Pre-Market
9/26/2014 8:23:00 AM - MT Newswires


Sector Update: Health Care
9/26/2014 8:21:14 AM - MT Newswires


Nektar Therapeutics Says Moventig Gets Positive CHMP Opinion In EU
9/26/2014 7:50:00 AM - RTT News


Nektar Therapeutics (NKTR) Shares Cross Below 200 DMA
9/22/2014 12:41:19 PM - BNK Invest


Salix' s Xifaxan 550 sNDA Under Review, Response by Feb 28 - Analyst Blog
9/19/2014 6:10:00 PM - Zacks.com


AstraZeneca's Constipation Drug Movantik Gets FDA Nod - Analyst Blog
9/17/2014 4:45:00 PM - Zacks.com


FDA Approves AstraZeneca, Nektar Constipation Drug--Update
9/16/2014 1:41:00 PM - Dow Jones Business News


Stocks Turning In Lackluster Performance As Fed Decision Looms - U.S. Commentary
9/15/2014 12:14:00 PM - RTT News


Stocks Move To The Downside, Tech-Heavy Nasdaq Underperforms - U.S. Commentary
9/15/2014 10:11:00 AM - RTT News


Weighing The Week Ahead: Finding Stocks For The 2014 Homestretch
9/7/2014 4:56:00 AM - Seeking Alpha


Weighing The Week Ahead: Finding Stocks For The 2014 Homestretch
9/7/2014 4:10:08 AM - SeekingAlpha


Nektar 181 Could Dominate A $13B Chronic Pain Market
8/26/2014 8:33:00 AM - Seeking Alpha


Monday's ETF Movers: FBT, GDX
8/25/2014 1:07:02 PM - BNK Invest


Positive Data on Baxter's Trial for BAX 855 - Analyst Blog
8/22/2014 6:30:00 PM - Zacks.com


Nektar Therapeutics Has More To Give
8/21/2014 1:45:00 PM - Seeking Alpha


2nd Half Of 2014 Biotechnology Catalysts--Part 4
8/17/2014 8:28:00 PM - Seeking Alpha


Nektar Therapeutics Harnesses The Power Of AstraZeneca To Move Movantik
8/7/2014 12:36:00 PM - Seeking Alpha


Nektar President Howard Robin Is Listening To You
8/4/2014 8:59:00 AM - Seeking Alpha


Nektar's Loss Narrows in Q2, Beats Revenues, Retains View - Analyst Blog
8/1/2014 1:53:00 PM - Zacks.com


Nektar: Reason Will Rarely Fail You
7/28/2014 10:24:00 AM - Seeking Alpha


Nektar Therapeutics (NKTR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
7/18/2014 8:00:00 AM - Zacks.com